Lixte Biotechnology Holdings, Inc.
- LIXT
- NASDAQ
- Biotechnology
- Cancer Drug Discovery
- Biomarker-Driven Therapeutics
$7.21
Today −6.00%Quote Jul 2, 2026, 08:00 PM UTC
−34.08%over the last month
Max drawdown −44.9%From 1-month high −44.9%3 months +42.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Lixte Biotechnology
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
3
Founded
2005
Market value
$89.1M
Quote Jul 2
Floor
$7.16
0.6% below price
Resistance
$8.19
13.6% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LIXTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free